Analysis of rodent growth data in toxicology studies

Statistics and Information Sciences, Lilly Research Laboratories, Eli Lilly and Company, Drop Code GL43, 2001 West Main Street, Greenfield, Indiana 46140, USA.
Toxicological Sciences (Impact Factor: 3.85). 05/2002; 66(2):313-9.
Source: PubMed


To evaluate compound-related effects on the growth of rodents, body weight and food consumption data are commonly collected either weekly or biweekly in toxicology studies. Body weight gain, food consumption relative to body weight, and efficiency of food utilization can be derived from body weight and food consumption for each animal in an attempt to better understand the compound-related effects. These five parameters are commonly analyzed in toxicology studies for each sex using a one-factor analysis of variance (ANOVA) at each collection point. The objective of this manuscript is to present an alternative approach to the evaluation of compound-related effects on body weight and food consumption data from both subchronic and chronic rodent toxicology studies. This approach is to perform a repeated-measures ANOVA on a selected set of parameters and analysis intervals. Compared with a standard one-factor ANOVA, this approach uses a statistical analysis method that has greater power and reduces the number of false-positive claims, and consequently provides a succinct yet comprehensive summary of the compound-related effects. Data from a mouse carcinogenicity study are included to illustrate this repeated-measures ANOVA approach to analyzing growth data in contrast with the one-factor ANOVA approach.

Download full-text


Available from: Robert van Lier, Jul 02, 2014
  • Source
    • "Multiple group comparisons of nonparametric data were conducted using the Kruskal – Wallis ANOVA on Ranks , followed by post hoc pairwise comparisons using the Dunn ' s method . Animal weights and relative food consumption ( food consumption / BW ) were analyzed by ANOVA on weekly average weights ( Hoffman , Ness , and van Lier 2002 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Exposure to the mycotoxin ochratoxin A (OTA) causes nephropathy in domestic animals and rodents and renal tumors in rodents and poultry. Humans are exposed to OTA by consuming foods made with contaminated cereal grains and other commodities. Management of human health risks due to OTA exposure depends, in part, on establishing a mode of action (MOA) for OTA carcinogenesis. To further investigate OTA's MOA, p53 heterozygous (p53+/-) and p53 homozygous (p53+/+) mice were exposed to OTA in diet for 26 weeks. The former are susceptible to tumorigenesis upon chronic exposure to genotoxic carcinogens. OTA-induced renal damage but no tumors were observed in either strain, indicating that p53 heterozygosity conferred little additional sensitivity to OTA. Renal changes included dose-dependent increases in cellular proliferation, apoptosis, karyomegaly, and tubular degeneration in proximal tubules, which were consistent with ochratoxicosis. The lowest observed effect level for renal changes in p53+/- and p53+/+ mice was 200 μg OTA/kg bw/day. Based on the lack of tumors and the severity of renal and body weight changes at a maximum tolerated dose, the results were interpreted as suggestive of a primarily nongenotoxic (epigenetic) MOA for OTA carcinogenesis in this mouse model. © 2015 by The Author(s).
    Toxicologic Pathology 02/2015; 43(5). DOI:10.1177/0192623314568391 · 2.14 Impact Factor
  • Source
    • "There were no significant effects on mean daily food consumption across dose and strain (data not shown). Since food consumption may be affected by body weight, the effect of FB 1 exposure on body weight-normalized food consumption (relative food consumption ) was evaluated by dividing food consumption by body weight for each week of the study (Hoffman et al., 2002). The effects of FB 1 on relative food consumption are summarized in Fig. 2A (WT) and B (TG). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The fungal toxin fumonisin B(1) (FB(1)) is a potential human carcinogen based on evidence of renal carcinogenicity in rats and hepatocarcinogenicity in mice. The toxicity and carcinogenicity of FB(1) is linked to ceramide synthase inhibition. Based on this mechanism of action and on lack of evidence of genotoxicity, FB(1) is considered a non-genotoxic carcinogen. The p53 heterozygous (p53+/-) mouse is a cancer-prone model used for carcinogenesis. The effects of chronic dietary FB(1) exposure were characterized in p53+/- mice to confirm non-genotoxicity using a model which is more sensitive to genotoxic than non-genotoxic carcinogens and to clarify the relationship between p53 expression, altered sphingolipid metabolism, and FB(1)-induced carcinogenesis. Responses to FB(1) were similar in p53+/- and p53+/+ mice after 26weeks exposure to 0, 5, 50 or 150mg FB(1)/kg diet, supporting a non-genotoxic mechanism of action. Hepatic adenomas and cholangiomas were observed in mice exposed to 150mg/kg FB(1). For a 10% increase in hepatic megalocytosis, the estimated 95% lower confidence limit of the benchmark dose (BMDL(10)) ranged from 0.15 and 1.11mg FB(1)/kg bw/day. Based on similar responses in p53+/- and p53+/+ mice, p53 and related pathways play a secondary role in responses to FB(1) toxicity and carcinogenesis.
    Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 07/2012; 50(10):3604-13. DOI:10.1016/j.fct.2012.07.024 · 2.90 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although scientists have used animal models for years to study the effects of ethanol (EtOH) ingestion on humans, the compounding effect of cigarette smoking has been virtually ignored. Because 80 to 95% of human alcoholics smoke, it is imperative to consider the added effects of smoking when trying to determine the consequences of excessive alcohol ingestion. We therefore have developed a rat model for studying the separate and combined results of smoking and drinking on human health. Male Sprague-Dawley rats were exposed daily for 12 weeks in whole-body chambers to cigarette smoke (smoke-exposed) or room air (sham-exposed). During the final 5 weeks of exposure, the rats were fed liquid diets that contained 0, 16, 26, or 36% EtOH calories. Smoke exposure was quantified by measurement of carboxyhemoglobin, nicotine, and cotinine levels. Body weights, food consumption, blood EtOH concentrations, and various assessments of liver damage and function also were followed. Smoke exposure in this rat model approximates that of a moderate to heavy human smoker. Smoke-exposed rats weighed significantly less and ate less food than sham-exposed controls, but both groups ingested equivalent amounts of EtOH for their body weights and had comparable blood EtOH levels. Liver aspartate and alanine aminotransferase levels remained normal. There was an EtOH-induced decrease in asialoglycoprotein receptor binding, but it was not exacerbated by smoke exposure. Alterations in blood cholesterol levels reflected what has been reported for humans, rising with increasing EtOH ingestion and decreasing with smoke exposure. Our rat model is relevant to what transpires in the vast majority of alcoholics. Both ethanol ingestion and smoke exposure can be manipulated to mimic light to moderate to heavy levels, making it appropriate for studying the separate and combined biomedical consequences of alcohol abuse and cigarette smoking.
    Alcoholism Clinical and Experimental Research 08/2004; 28(7):1120-8. DOI:10.1097/01.ALC.0000136383.45378.91 · 3.21 Impact Factor
Show more